Bifeprunox: a novel atypical antipsychotic sharing dopamine D(2,3,4) receptor and serotonin 5-HT(1A) receptor affinities

被引：0
|
作者：
Marquis, K
Hertel, P
Reinders, JH
Van der Neut, M
Ronken, E
McCreary, AC
Herremans, AHJ
Hesselink, MB
机构：
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S487 / S487
页数：1
相关论文
共 50 条
  • [1] Bifeprunox:: A novel atypical antipsychotic sharing dopamine D2 receptor partial agonism and serotonin 5-HT1A receptor agonism
    Marquis, KL
    Hertel, P
    Reindeers, JH
    van der Neut, M
    Ronken, E
    Hesselink, MB
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 305 - 305
  • [2] Bifeprunox:: a novel atypical antipsychotic with in vivo 5-HT1A receptor agonistic activity
    Herremans, AHJ
    Hertel, P
    Husum, H
    Marquis, K
    Van der Heyden, J
    McCreary, AC
    Hesselink, MB
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S488 - S488
  • [3] New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D2-receptor and serotonin 5-HT1A-receptor affinities
    Feenstra, RW
    de Moes, J
    Hofma, JJ
    Kling, H
    Kuipers, W
    Long, SK
    Tulp, MTM
    van der Heyden, JAM
    Kruse, CG
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (17) : 2345 - 2349
  • [4] Combined serotonin (5-HT)1A agonism, 5-HT2A and dopamine D2 receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats
    Oyamada, Yoshihiro
    Horiguchi, Masakuni
    Rajagopal, Lakshmi
    Miyauchi, Masanori
    Meltzer, Herbert Y.
    BEHAVIOURAL BRAIN RESEARCH, 2015, 285 : 165 - 175
  • [5] Serotonin (5-HT) hyperpolarized orexin neurons via a 5-HT 1A receptor
    Muraki, Y
    Yamanaka, A
    Tsujino, N
    Hirashima, N
    Sakuri, T
    Goto, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 76P - 76P
  • [6] Bifeprunox:: A new atypical antipsychotic with in vivo, agonistic activity at the 5-HT1A receptor
    Hertel, P
    Husum, H
    Marquis, K
    Herremans, AHJ
    Hesselink, MB
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 83 - 83
  • [7] Bifeprunox: a novel antipsychotic agent with partial agonist properties at dopamine D2 and serotonin 5-HT1A receptors
    Wadenberg, Marie-Louise G.
    FUTURE NEUROLOGY, 2007, 2 (02) : 153 - 165
  • [8] CHRONIC, COMBINED TREATMENT WITH DESIPRAMINE AND MIANSERIN - ENHANCED 5-HT(1A) RECEPTOR FUNCTION AND ALTERED 5-HT(1A)/5-HT(2) RECEPTOR INTERACTION IN RATS
    LUND, A
    MJELLEM, N
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 45 (04) : 777 - 783
  • [9] Atypical antipsychotic profile of NRA0045, a novel dopamine D4 receptor, 5-hydroxytryptamine2A (5-HT2A) receptor and α1 adrenoceptor antagonist
    Chaki, S
    Nakazato, A
    Okuyama, S
    CNS DRUG REVIEWS, 2000, 6 (02): : 95 - 110
  • [10] Serotonin 5-HT2 receptor, dopamine D-2 receptor, and alpha(1) adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole
    Andersen, K
    Liljefors, T
    Hyttel, J
    Perregaard, J
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (19) : 3723 - 3738
12345